Alnylam Pharmaceuticals, Inc. (ALNY)

Market price: $226.54

6 valuation methods

• P / B: $23.87 to $85.51 (midpoint $48.72)
• EV / EBITDA: $115.08 to $299.40 (midpoint $149.36)
• EV / Revenue: $114.25 to $221.58 (midpoint $154.62)
• P / E: $109.98 to $362.90 (midpoint $157.17)
• EV / Gross Profit: $157.19 to $364.30 (midpoint $205.15)
• DCF (FCFF): $276.92 to $387.75 (midpoint $323.47)